Background: Sweat chloride test is the gold standard test for cystic fibrosis (CF) diagnosis. 
Introduction
Diagnostic testing in CF is based on the sweat chloride test (SCT) in the context of appropriate signs and symptoms of disease and results of the cystic fibrosis transmembrane regulator (CFTR) protein mutation analysis. The SCT is a wellestablished functional assessment of CFTR that has been available for decades to diagnose CF (Gibson LE, 1959) and, recently, to test the effect of CFTR potentiators (Accurso et al., 2014) 
Sweat testing is currently performed in approximately 37 laboratories across
Italy belonging to the Italian public Referral Centers and in many other laboratories not belonging to such Centers. However the absence of any updated census doesn't allow knowing exactly the total number of laboratories performing SCT nationwide.
It is of critical importance that SCT is carried out accurately with measurement of relevant analytes to allow clinical interpretation of results. Italian audit performed in 2008 showed areas of inconsistencies in current practices for SCT, highlighting the needs of national guidelines to improve practice and management strategies (Cirilli et al, 2008; Cirilli et al, 2008) . In order to increase and monitor quality in laboratory performing SCT, an EQA SCT pilot program was performed in 2014 at the Italian National Centre for Rare Diseases (CNMR) of the Istituto Superiore di Sanità (ISS, Rome); in 2015 the activity was recognized as institutional through the publication of Official Bulletin of the Italian Republic (Official Bulletin of the Italian Republic, 2015; Salvatore et al, 2016) and the SCT EQA program is now permanent. Aim of this study is to report results of the first official 2015 sweat chloride test EQA program compared with the 2014 round ones. Salvatore et al. 35 Table 1: IEQ-TS 2015 general results The pilot IEQA-SCT has been fully described by Salvatore et al. (Salvatore et al., 2016) . Overall, ten and thirteen laboratories, included among the 37 Italian CF public Referral Centers, participated in 2014 and 2015 respectively. Journal of Chemistry and Biochemistry, Vol. 4(2), December 2016
Methods
All data were managed through a web utility (Salvatore et al, 2016 Biology, SIBiOC), both online and collegially in a dedicated meeting.
Results
In 2015 
Qualitative description of the laboratories
All laboratories, except one (laboratory i), participating in both experiences reached an optimum score ranking from 8/10 to 10/10 (Table 1) 
Reports assessment
Almost all reports were incomplete, missing information concerning one or more parameters. Scores ranged from 3,5/10 to 10/10 and most frequently missing information concerned "interpretation of results" (15,4%, in sample SLS-1; 30,8% in sample SLS-2 and 15,4% sample SLS-3), "reference intervals" (23,0%, in SLS-1;
30,8% in SLS-2 and 15,4% in SLS-3), and "date of primary sample collection" (15, 4%, 15, (1) (2) (3) . No difference was detected among laboratories participating both in 2014 and 2015.
Conclusions
Sweat chloride test is the gold standard to diagnose CF and to monitor patients during molecular therapies, where accurate results are required. Recent papers identify different issues about laboratories standardization in execution, interpretation and reporting of results (Cirilli et al, 2008; Cirilli et al, 2012; LeGrys 2000; LeGrys 2001; Kirk JM, 2000) . Currently we cannot exclude that errors are due to methodological, equipment or technical problems caused by the unskilled personnel (Miller WG et al, 2011) . Heterogeneity was observed in the modality of results reporting. Most frequently missing information concerned "reference intervals", "date of primary sample collection" and in particular "interpretation" that affected clinical sensitivity as previously discussed.
Variability in results also indicates that until EQA participation becomes mandatory as a component of compulsory laboratory accreditation, the quality of laboratory performance is unpredictable (Hastings et al, 2008) . Moreover, it is noteworthy to underline that two laboratories making a wrong chloride titration in one or more samples in the 2014 pilot scheme didn't address the internal analytical problem and performed poorly also in the 2015 round for two samples. In this respect, it is generally a good idea for laboratories to have well-written standard operating procedures that are based on published guidelines; these should, along with training, address the issues of execution, interpretation and reporting of results.
Currently we are harmonizing the activity of this program with existing Italian and European EQA schemes and improving the structure of the program by a new marking system when two categories of performance are defined, i.e. poor and satisfactory. Moreover, it would be desirable to combine a quality control program to an implementation plan of quality improvement.
